USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
Switzerland
93911242.1
Filed on 1993-05-13
93911242.1
Filed on 1993-05-13
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
Spain
93911242.1
Filed on 1993-05-13
93911242.1
Filed on 1993-05-13
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
Japan
1994-500936
Filed on 1993-05-13
1994-500936
Filed on 1993-05-13
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
Italy
93911242.1
Filed on 1993-05-13
93911242.1
Filed on 1993-05-13
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
Germany
93911242.1
Filed on 1993-05-13
93911242.1
Filed on 1993-05-13
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
France
93911242.1
Filed on 1993-05-13
93911242.1
Filed on 1993-05-13
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
European Patent
93911242.1
Filed on 1993-05-12
93911242.1
Filed on 1993-05-12
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
Canada
2135312
Filed on 1993-05-12
2135312
Filed on 1993-05-12
USE OF INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE AS A MODALITY IN CANCER THERAPY
Austria
93911242.1
Filed on 1993-05-13
93911242.1
Filed on 1993-05-13